The knowledge that specific epigenetic lesions appear in the metastatic cells from both tumour types, such as CDH11 hypermethylation, gives us a better understanding of the molecular setting that leads to dissemination and may suggest new biomarkers and therapeutic targets for the advanced forms of the disease. The gene discussed is CDH11; the disease is neoplasm.